59
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T80382 |
EP2
|
||
EP2是一种具有抗菌功能的肽类化合物,展现出明显的抗细菌和抗真菌活性。针对E. gallinarum, P. pyocyanea, A. baumanii, K. terrigena,其最小抑菌浓度(MIC)为11.4 μg/mL。 | |||
T67946 |
EP2 receptor antagonist-2
|
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
EP2 receptor antagonist-2 (CID891729)为EP2受体拮抗剂,能够抑制PGE2诱导的EP2受体激活,并阻断由N-甲基-D-天冬氨酸(NMDA)引起的乳酸脱氢酶(LDH)释放。 | |||
T62641 | EP2 receptor antagonist-1 | ||
EP2 receptor antagonist-1 是一种可逆的、有效的、激动剂依赖性变构的前列腺素 EP2 受体拮抗剂。EP2 receptor antagonist-1 表现出抗炎活性。 | |||
T37088L |
pep2m aceate
|
Others | Others |
pep2m aceate 是 GluR2 亚基 C 端与 N-乙基马来酰亚胺敏感融合蛋白相互作用的肽抑制剂。 | |||
TP1943L1 |
pep2-EVKI acetate(1315378-67-6 free base)
|
GluR | Neuroscience |
pep2-EVKI acetate(1315378-67-6 free base) 是一种细胞渗透性肽。 它干扰与 C 激酶 (PICK1) 相互作用的蛋白质和 GluR2 AMPA 受体亚基之间的相互作用。 | |||
TP1945L1 |
Pep2m, myristoylated acetate
Pep2m, myristoylated acetate(1423381-07-0 free base) |
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
Pep2m, myristoylated acetate(1423381-07-0 free base) 是一种细胞可渗透的肉豆蔻酰化形式的 pep2m。 GluA2(AMPA 受体)亚基的 C 末端与 N-乙基马来酰亚胺敏感融合蛋白 (NSF)(一种调节 AMPA 受体功能的蛋白质)之间相互作用的肽抑制剂。降低 CA1 神经元中的突触后电流、培养的海马神经元中 AMPA 介导的电流和 AMPA 受体表面表达。 | |||
TP1942L1 |
pep2-AVKI acetate(1315378-69-8 free base)
|
Others | Others |
pep2-AVKI acetate(1315378-69-8 free base) 选择性破坏 AMPA 受体亚基 GluA2(在 C 末端 PDZ 位点)与与 C 激酶 (PICK1) 相互作用的蛋白质结合的抑制剂肽。不影响 GluA2 与 GRIP 或 ABP 的结合,也不增加 AMPA 电流幅度或影响长期抑制 (LTD)。 | |||
TP1944L1 |
pep2-SVKI acetate
pep2-SVKI acetate(328944-75-8 free base) |
GluR | Neuroscience |
Pep2-SVKI acetate(pep2-SVKI acetate (328944-75-8 free base)) 是一种合成肽盐,可防止 AMPA 型谷氨酸受体的内化。 | |||
TP1881 |
Pep2-8
Pep 2-8 |
||
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor. Potent inhibitor of PCSK9 binding to LDL receptor (IC50 = 0.8 μM). Restores LDL uptake in HepG2 cells treated with PCSK9. | |||
T37088 |
pep2m
pep2m |
||
pep2m 可用于生命科学领域的相关研究。其产品编号为 T37088,CAS号为 243843-42-7。 | |||
TP1942 |
pep2-AVKI
|
||
pep2-AVKI is an inhibitor peptide that selectively disrupts binding of the AMPA receptor subunit GluA2 (at the C-terminal PDZ site) to protein interacting with C kinase (PICK1). Does not affect binding of GluA2 to GRIP or ABP and does not increase AMPA current amplitude or affect long term depression (LTD). | |||
TP1943 |
pep2-EVKI
|
||
pep2-EVKI is an inhibitor peptide that selectively disrupts binding of the AMPA receptor subunit GluA2 (at the C-terminal PDZ site) to protein interacting with C kinase (PICK1). Does not affect binding of GluA2 to GRIP or ABP and does not increase AMPA current amplitude or affect long term depression (LTD). | |||
T75937 |
Pep2m, myristoylated TFA
|
||
Pep2m, myristoylated TFA (Myr-Pep2m TFA)为具备细胞渗透性的肽。该化合物通过破坏PKMζ与其下游靶点NSF/GluR2的相互作用而发挥作用,其中PKMζ为具有自主活性的PKC同工酶。 | |||
TP1944 |
pep2-SVKI
|
||
Inhibitor peptide corresponding to last 10 amino acids of the C-terminus of the GluA2 AMPA receptor subunit. Disrupts binding of GluA2 (at the C-terminal PDZ site) with glutamate receptor interacting protein (GRIP), AMPA receptor binding protein (ABP) and | |||
T83922 |
Pep2 Peptide
|
||
Pep2 peptide是一种针对跨膜糖蛋白CD36的肽配体,CD36也被称为清道夫受体B2。在1 mM浓度使用时,Pep2 peptide在无细胞检测中选择性地与CD36结合,相比于人血清白蛋白(HSA)、IgG和CD44具有更高的亲和力。与不含Pep2 peptide的胶束相比,包裹抗癌剂多柔比星的Pep2 peptide功能化胶束能增加多柔比星在过表达CD36的HepG2肝细胞癌细胞中的细胞内输送,并提升细胞毒性。 | |||
TP1945 |
Pep2m, myristoylated
|
||
Cell-permeable, myristoylated form of pep2m. Peptide inhibitor of the interaction between the C-terminus of the GluA2 (AMPA receptor) subunit and N-ethylmaleimide-sensitive fusion protein (NSF), a protein that regulates AMPA receptor function. Reduces pos | |||
T78013 |
Pep2-8 TFA
|
||
Pep2-8是增强PCSK9拮抗活性的肽,作用于前蛋白转化酶枯草杆菌蛋白酶/可辛9型(PCSK9)。 | |||
T37087 |
pep2-SVKE
pep2-SVKE |
||
pep2-SVKE 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 T37087,CAS号为 1315378-76-7。 | |||
T82566 |
DiaPep277
|
||
DiaPep277为源自HSP60第437-460位点的24个氨基酸组成的多肽,能够抑制NOD小鼠β-细胞破坏进展,并在糖尿病动物模型中对T细胞表现出免疫调节功能。 | |||
T3306 |
PF-04418948
PF 04418948,PF04418948 |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
PF-04418948 是一种可口服的,选择性的前列腺素EP2受体拮抗剂,IC50为16 nM。 | |||
T14148 |
AH 6809
|
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
AH 6809 是 EP 和 DP 受体的拮抗剂,对小鼠 EP2受体的 Ki 值为 350 nM,对克隆的人类 EP1,EP2,EP3-III 和 DP 受体的 Ki 值分别为 1217、1150、1597 和 1415 nM。 | |||
T2428 |
TG6-10-1
|
5-HT Receptor; Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation; Neuroscience |
TG6-10-1 是一种 EP2 拮抗剂。 | |||
T5482 |
TG4-155
|
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
TG4-155 是一种脑渗透性 EP2 拮抗剂,对 EP2 和 DP1 具有低纳摩尔的拮抗活性。它作用于 EP2 的 KB 为 2.4 nM,比对 DP1 受体的选择性高 14 倍,比对 EP1、EP3、EP4 和 IP 的选择性比高 550-4750 倍。 | |||
T8603 |
ETHYL 2-AMINO-4-METHYL-5-PHENYLTHIOPHENE-3-CARBOXYLATE
|
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
ETHYL 2-AMINO-4-METHYL-5-PHENYLTHIOPHENE-3-CARBOXYLATE 靶向前列腺素 E2受体 EP2亚型(人)。 | |||
T5150 |
Treprostinil
LRX-15,曲前列环素,Orenitram,曲前列尼尔,Remodulin |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
Treprostinil (Orenitram) 是有效的 DP1、IP 和 EP2 激动剂,EC50分别为0.6、1.9 和 6.2 nM。 | |||
T28958 |
TG6-129
TG6 129 |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
TG6-129 是有效的EP2受体选择性拮抗剂,可降低 butaprost 诱导的 P388D1 巨噬细胞中炎症因子的表达。 | |||
T63349 |
Treprostinil diethanolamine
UT-15C |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
Treprostinil diethanolamine (UT-15C) 是EP2、DP1和IP 的有效激动剂,对EP2、DP1、IP、EP1、EP4、EP3 和 FPKi 的值分别为 3.6、4.4、32.1、212、826、2505 和 4680 nM。Treprostinil diethanolamine 能够促使 cAMP 的上调,进而维持血管系统内的稳态,并造成人肺动脉的血管扩张。 | |||
T5171 |
Treprostinil Sodium
曲前列尼尔钠,UT-15 |
VEGFR; c-RET; Prostaglandin Receptor | Angiogenesis; Apoptosis; GPCR/G Protein; Immunology/Inflammation; Tyrosine Kinase/Adaptors |
Treprostinil Sodium (UT-15) 是有效的 DP1、IP 和 EP2 激动剂,EC50分别为0.6、1.9 和 6.2 nM。 | |||
T11211 |
EP4 receptor antagonist 1
|
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
EP4 receptor antagonist 1 是一种有效的特异性前列腺素 EP4受体拮抗剂,对人和小鼠 EP4受体的 IC50分别为6.1 nM 和16.2 nM。 EP4 receptor antagonist 1 可用于癌症免疫治疗的研究。 | |||
T14975 |
CJ-42794
CJ-042794 |
Others | Others |
CJ-42794 (CJ-042794)是前列腺素受体 EP4的选择性拮抗剂, 抑制[3H]-PGE2与 EP4受体结合的平均 pKi 为8.5, 对 EP4选择性比 EP1, EP2和 EP3高200多倍。 | |||
T15259 |
Evatanepag
CP-533536 free acid,2-[3-[N-(4-叔丁基苄基)-N-(吡啶-3-基磺酰基)氨基甲基]苯氧基]乙酸 |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
Evatanepag (CP-533536 free acid) 是一种 EP2 受体选择性前列腺素 E2 (PGE2) 激动剂,可诱导局部骨形成,EC50 为 0.3 nM。它在大鼠骨折愈合模型中以单剂量局部给药时表现出愈合骨折的能力。 | |||
T16389 | Omidenepag | Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
Omidenepag is a pharmacologically active form of Omidenepag Isopropyl and is a selective, non-prostanoid EP2 receptor agonist (EC50: 1.1 nM). Omidenepag displays binding affinities (IC50: 10 nM for h-EP2). | |||
T14146 |
AGN 210676
Simenepag |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
AGN 210676 is a selective agonist of prostaglandin EP2(EC50 : 5 nM). | |||
T26578 |
AH13205
AH-13205,AH 13205 |
||
AH13205 is an agonist of EP2 prostanoid receptor. | |||
T15689 |
L-798106
CM9,GW671021 |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
L-798106 is a highly selective prostanoid EP3 receptor antagonist (Ki=0.3 nM). It also has micromolar activities at EP4, EP1, and EP2 receptors (Ki: 916 nM, >5000 nM, and >5000 nM at EP4, EP1, and EP2, respectively). | |||
T14139 |
Aganepag
AGN 210937 |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
Aganepag, a potent Prostanoid EP2 receptor agonist, exhibits remarkable selectivity with an EC50 of 0.19 nM, demonstrating no activity at the EP4 receptor. Its applications are primarily in the fields of wound healing, scar reduction, scar prevention, and the treatment and prevention of wrinkles. | |||
T16988 |
Taprenepag isopropyl
PF-04217329 |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
Taprenepag isopropyl is a highly selective agonist of the EP2 receptor. | |||
T26263 |
TG3-95-1
TG3951,TG 3951,TG-3951 |
||
TG3-95-1 is an EP2 allosteric potentiator agent. | |||
T68514 | PGN-9856 | ||
PGN-9856 is a novel potent, selective prostaglandin EP2 receptor agonist | |||
T69256 | ONO-AE1-259 lysine | ||
ONO-AE1-259 is a highly selective agonist of prostaglandin e2 receptor (ep2) | |||
T29707 |
Aganepag ethanediol
AGN-212409,AGN212409 |
||
Aganepag ethanediol 是一种降低眼压的抗青光眼化合物。Aganepag ethanediol 是一种选择性 EP2 受体激动剂。 | |||
T16388 |
Omidenepag isopropyl
|
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
Omidenepag isopropyl is converted to the active product Omidenepag during corneal penetration. Omidenepag isopropyl is a selective EP2 receptor agonist. Omidenepag isopropyl displays only a weak affinity for EP1, EP2, and FP receptors. Omidenepag isopropy | |||
T69608 |
TG11-77 HCl
|
||
TG11-77 HCl is a novel, Potent, Selective, Water Soluble, Brain-Permeable EP2 Receptor Antagonist. TG11-77 HCl has a Schild KB of 9.7 nM on EP2, a water solubility of 2.5 mM, a brain-to-plasma ratio of 0.4, and a plasma half-life of 2.4 h in mice. TG11-77 HCl are representative second generation EP2 antagonists with improved pharmacodynamic and pharmacokinetic properties. | |||
T69609 |
TG11-77 free base
|
||
TG11-77 free base is a novel, Potent, Selective, Water Soluble, Brain-Permeable EP2 Receptor Antagonist. TG11-77 free base has a Schild KB of 9.7 nM on EP2, a water solubility of 2.5 mM, a brain-to-plasma ratio of 0.4, and a plasma half-life of 2.4 h in mice. TG11-77 free base are representative second generation EP2 antagonists with improved pharmacodynamic and pharmacokinetic properties. | |||
T69755 |
Evatanepag sodium
|
||
Evatanepag, also known as CP-533536, is an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation. CP-533536 demonstrated the ability to heal fractures when administered locally as a single dose in rat models of fracture healing. | |||
T15642 | KAG-308 | Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
KAG-308 is an effective selective and orally active agonist of the EP4 receptor (Ki: 2.57 nM and EC50: 17 nM for human EP4 receptor), more selective over EP1, EP2, EP3, and IP receptor. KAG-308 suppresses colitis and promotes histological mucosal healing, | |||
T41369 |
(S)-Butaprost free acid
|
||
(S)-Butaprost (free acid) 是有效的、选择性的EP2受体激动剂。 | |||
T10046 |
16,16-Dimethyl prostaglandin E2
16,16-dimethyl PGE2 |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
16,16-Dimethyl prostaglandin E2 is an orally active vertebrate Hematopoietic stem cells homeostasis critical regulator. It can act through EP2/EP4 and has an interaction with the Wnt pathway. | |||
T26925 |
Butaprost
Butaprostum,TR-4979,(R)-Butaprost |
||
Butaprost is a chemical compound that functions as a selective agonist for the prostaglandin E receptor (EP2). It exhibits an EC50 of 33 nM and a Ki of 2.4 μM when interacting with the murine EP2 receptor. However, Butaprost demonstrates lower activity against murine EP1, EP3, and EP4 receptors. Furthermore, it effectively attenuates fibrosis by inhibiting the TGF-β/Smad2 signaling pathway [1] [2] [3]. | |||
T39165 |
Treprostinil palmitil
Treprostinil palmitil,INS-1009 |
||
Treprostinil Palmitil (TP), a prodrug of the DP1 and EP2 agonist Treprostinil (UT-15), exhibits EC50 values of 0.6 and 6.2 nM, respectively. It is a pure prodrug without any inherent binding affinity for G-protein coupled receptors, including prostanoid receptors. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1626 |
Prostaglandin E1
前列地尔,PGE1,列腺素E1,Alprostadil |
Endogenous Metabolite; Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation; Metabolism |
Prostaglandin E1 (Alprostadil) 是一种前列腺素受体配体,对小鼠 EP1、EP2、EP3、EP4和 IP 的 Ki 值分别为 36、10、1.1、2.1 和 33 nM。它诱导血管舒张并抑制血小板聚集,可作为血管扩张剂用于外周血管疾病的研究。 |